Test Price
2,800 AED✅ Home Collection Available
TIMM8A Gene Dystonia-Deafness Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Post-Test Telephonic Clinical Interpretation by Consultant Medical Genetics and Genetic Counselor.
- Insurance & Payment: Direct Billing Verification via WhatsApp at +971 54 548 8731.
- UAE Compliance: Aligned with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The TIMM8A NGS test sequences the entire coding region of the TIMM8A gene to identify pathogenic variants causing Mohr‑Tranebjaerg syndrome (Dystonia‑Deafness Syndrome), a rare X‑linked disorder. It is the definitive molecular diagnostic tool for early neurological intervention and genetic family planning, widely recommended by UAE specialists for at‑risk patients.
| Parameter | Our Test (Premium NGS) | Alternative (Sanger / Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS), full gene | Single‑gene Sanger, limited hot‑spot |
| Analytical Sensitivity | >99.9% (all variant types) | ~95% for targeted regions |
| Turnaround Time | 3 – 4 Weeks | 2 – 3 Weeks |
| Clinical Reporting | DHA‑compliant, detailed ACMG classification | Basic pathogenic / benign call |
| Cost (AED) | 2800 AED | ~1500 – 2000 AED |
Physician Insight & Safety Protocols
“Genetic testing for TIMM8A provides a definitive diagnosis for Mohr‑Tranebjaerg syndrome, but results must be correlated with clinical presentation and family history. Our multidisciplinary team ensures comprehensive interpretation and counseling. Always consult your physician before making any treatment decisions based on test results.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety & Important Precautions
Medication Safety Warning
Do not discontinue prescribed medication without consulting your doctor.
Stopping anti‑dystonic or neurological drugs abruptly can cause severe withdrawal symptoms and status dystonicus.
Exclusion Criteria & Emergency Red Flags
- Individuals with a confirmed non‑genetic aetiology for dystonia and deafness (e.g., acquired cochlear damage).
- Patients requiring urgent surgical intervention for movement disorders – genetic testing should not delay emergency management.
- Red Flag: Sudden onset severe dystonic storm, respiratory compromise, or suicidal ideation → proceed to nearest emergency immediately.
Patient FAQ & Clinical Guidance
1. What is the TIMM8A gene test and why is it performed?
A: The TIMM8A genetic test sequences the entire coding region of the TIMM8A gene to diagnose Mohr‑Tranebjaerg syndrome, a rare X‑linked disorder causing dystonia and deafness, enabling precise family risk assessment and management.
2. How accurate is this NGS test?
A: Our TIMM8A NGS test achieves >99.9% analytical sensitivity and specificity, validated by ISO 9001:2015 certified processing and DHA‑licensed clinical interpretation.
3. How is the sample collected and what are the requirements?
A: Sample collection is performed via a simple blood draw or FTA card at your home by a DHA‑licensed phlebotomist, with pre‑genetic counselling included to draw a pedigree chart. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM.
4. How long does it take to get results?
A: The turnaround time is 3 to 4 weeks from sample receipt. A detailed clinical report with ACMG variant classification is provided.
5. How do I book the test and what is the cost?
A: The cost is 2800 AED. You can book via WhatsApp at +971 54 548 8731. Insurance billing can be verified in advance.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143. All genetic testing and patient data handling strictly adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical laboratory processes are ISO 9001:2015 certified. Patient consent and medical liability follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | TIMM8A Gene Sequencing (Dystonia-Deafness Syndrome) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coding Region |
| ICD-10-CM Code | G24.1, H90.5 |
| LOINC Code | 93175-2 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
Support: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians